Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001494650-22-000043
Filing Date
2022-04-26
Accepted
2022-04-26 16:12:37
Documents
2
Period of Report
2022-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_165100394303938.html 3  
1 FORM 3 wf-form3_165100394303938.xml 3 1687
2 POWER OF ATTORNEY R JOHN FLETCHER ex-24.htm EX-24 3458
  Complete submission text file 0001494650-22-000043.txt   6536
Mailing Address C/O VYANT BIO, INC. 201 ROUTE 17 NORTH, 2ND FLOOR RUTHERFORD NJ 07070
Business Address
FLETCHER R JOHN (Reporting) CIK: 0001215024 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38241 | Film No.: 22854446

Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Issuer) CIK: 0001494650 (see all company filings)

EIN.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations